{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"715.013235","value":"1123.73333"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"30"}],"units":"Participants"}],"description":"Serum concentration of alisertib on the fourth day of administration prior to the administration of the day 4 dose in nanograms/milliliter.","dispersionType":"Standard Deviation","groups":[{"description":"All patients.","id":"OG000","title":"All Patients"}],"paramType":"MEAN","populationDescription":"Of all eligible patients enrolled, 30 provided a fourth day of administration prior to the administration of the day 4 dose sample for analysis.","reportingStatus":"POSTED","timeFrame":"day 4 of protocol therapy","title":"Serum Concentration of Alisertib on the Fourth Day of Administration Prior to the Administration of the Day 4 Dose","type":"SECONDARY","unitOfMeasure":"ng/ml"}